Literature DB >> 8549410

Ciprofloxacin in the treatment of serious infections in systemic lupus erythematosus.

H M Oh1, W H Koh, M L Boey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549410     DOI： 10.2165/00003495-199500492-00144

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  3 in total

1.  Ciprofloxacin treatment of acute infections in immunocompromised host.

Authors:  G Nemes; Y Heuser; D Stolle; H D Piroth; P Nemes
Journal:  J Chemother       Date:  1989-07       Impact factor: 1.714

2.  Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients.

Authors:  M E Wood; A C Newland
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

3.  Oral ciprofloxacin therapy for infections in cancer patients.

Authors:  E Haron; K V Rolston; C Cunningham; F Holmes; T Umsawasdi; G P Bodey
Journal:  J Antimicrob Chemother       Date:  1989-12       Impact factor: 5.790
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.